This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Inova Health System Re-Ups System-wide Pulse Oximetry Contract With Masimo

Stocks in this article: MASI

FAIRFAX, Va. and IRVINE, Calif., Sept. 19, 2012 /PRNewswire/ -- Inova Health System, one of the largest healthcare systems in Northern Virginia and the Washington D.C. metro area, today renewed its long-standing contract and commitment to Masimo SET ® as its pulse oximetry standard-of-care.

The new five-year contract now includes Inova Loudoun Hospital – making Masimo pulse oximetry technologies and devices the standard-of-care for all care areas of five hospitals within the Inova Health System, including Inova Fairfax Hospital, rated No. 1 in the Washington, D.C. area on the 2012-2013 U.S. News & World Report honor roll. The contract also adds Masimo rainbow ® SET ® measurement capabilities with Masimo's handheld Rad-57™ Pulse CO-Oximeter™, designed to deliver rapid noninvasive blood measurements for improved patient assessments.

Inova Health System standardized on Masimo SET ® pulse oximetry technology for Measure-Through Motion and Low Perfusion SpO 2, pulse rate, and perfusion index measurements more than seven years ago because it virtually eliminates false alarms 1 and increases a clinician's ability to detect life-threatening events 2. More than 100 independent clinical studies have confirmed that Masimo SET ® technology allows clinicians to accurately monitor blood oxygen saturation in the most challenging conditions – establishing the technology as an industry-leading pulse oximetry that substantially contributes to improved patient outcomes.

Today, the health system is expanding its relationship with Masimo and deploying two new Masimo rainbow ® SET ® Pulse CO-Oximetry measurements: carboxyhemoglobin (SpCO®) and methemoglobin (SpMet®), which help clinicians measure and detect carbon monoxide and methemoglobin blood levels without a painful needle stick or time-consuming blood lab analysis 3,4. Masimo rainbow ® SET ® technology has been shown to have the highest pulse oximetry specificity (lowest rate of false alarms) and sensitivity (highest true alarm detection), 2 as well as noninvasive patient monitoring solutions that allow clinicians to measure multiple blood constituents – including: oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), acoustic respiration rate (RRa™), and perfusion index (PI) in addition to the Measure-Through Motion and Low Perfusion performance of Masimo SET® oxyhemoglobin (SpO 2), and pulse rate (PR).

Thanks to Masimo's upgradable technology platform, Inova's existing Radical-7 ® bedside monitors can be upgraded to include additional Masimo rainbow ® SET ® measurements via a simple software upgrade that may be purchased at any time. No additional hardware or devices are required to obtain Masimo's full suite of noninvasive rainbow ® SET ® measurements – saving the health system time and money.

1 Shah N, Ragaswamy HB, Govindugari K, Estanol L "Performance of Three New-Generation Pulse Oximeters during Motion and Low Perfusion in Volunteers". J Clin Anesth. 2012 Aug;24(5):385-91.

2 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study."  Anesthesiology, February 2010, Vol. 112, Issue 2. Available online  here.

3 Suner, S. Noninvasive Pulse CO-Oximetry Screening in the Emergency Department Identifies Occult Carbon Monoxide Toxicity. J Emerg Med 2007; 34(4):441-450.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs